UnitedHealth Group Incorporated (UNH)

Check out top investors' recommendation for UNH
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company’s UnitedHealthcare segment offers consumer-oriented health benefit plans and services for large national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals aged 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; health plans and care programs to beneficiaries of acute and long-term care Medicaid plans; and specialty benefits, such as dental, vision, life, and disability products. This segment serves through a network of 780,000 physicians and other health care professionals, and 5,900 hospitals. Its OptumHealth segment provides health management services, integrated care delivery services, consumer relationship management, sales distribution platform services, and financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery system. The company’s OptumInsight segment offers software and information products, advisory consulting services, and business process outsourcing services to hospitals, physicians, commercial health plans, government agencies, life sciences companies, and other organizations. Its OptumRx segment provides pharmacy benefit management services and programs, including claims processing, retail network contracting, rebate contracting, and management; and clinical programs, such as step therapy, formulary management, and disease/drug therapy management programs. This segment also offers patient support programs and dispensing of prescribed medications through its mail order pharmacies for its clients’ members. The company was founded in 1974 and is based in Minnetonka, Minnesota.
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
John Ransom Raymond James Buy   Sep 24, '18     304.00  Sep 24, '19  N/A 
Charles Rhyee Cowen And Company Buy   Sep 17, '18     308.00  Sep 17, '19  N/A 
Steven Halper Lazard Capital Markets Buy   Aug 09, '18     300.00  Aug 09, '19  N/A 
Matthew Borsch Goldman Sachs Buy   Jun 07, '18     285.00  Jun 07, '19  N/A 
Steven Halper Lazard Capital Markets Buy   Mar 08, '18     280.00  Mar 08, '19  N/A 
David Toung Argus Research Company Buy   Jan 18, '18     270.00  Jan 18, '19  N/A 
Michael Wiederhorn Oppenheimer & Co. Buy   Jan 16, '18     240.00  Jan 16, '19  N/A 
Steven Halper Lazard Capital Markets Buy   Jan 16, '18     235.00  Jan 16, '19  N/A 
Sarah James Wedbush Securities Inc. Buy   Jan 16, '18     259.00  Jan 16, '19  N/A 
David Windley Jefferies & Co. Buy   Jan 12, '18     280.00  Jan 12, '19  N/A 
Christine Arnold Cowen And Company Buy   Jan 12, '18     260.00  Jan 12, '19  N/A 
Sarah James Wedbush Securities Inc. Buy   Nov 29, '17     242.00  Nov 29, '18  N/A 
Michael Wiederhorn Oppenheimer & Co. Buy   Nov 28, '17     225.00  Nov 28, '18  N/A 
Steven Halper Lazard Capital Markets Buy   Nov 27, '17     225.00  Nov 27, '18  N/A 
Ana Gupte Dowling & Partners Securities, LLC Buy   Oct 18, '17     240.00  Oct 18, '18  N/A 
Steven Halper Lazard Capital Markets Buy   Oct 17, '17     208.00  Oct 17, '18  N/A 
Michael Wiederhorn Oppenheimer & Co. Buy   Oct 17, '17     205.00  Oct 17, '18  N/A 
Sheryl Skolnick CRT Capital Group Buy   Oct 06, '17     235.00  Oct 06, '18  N/A 
David Windley Jefferies & Co. Buy   Sep 20, '17     215.00  Sep 20, '18  N/A 
Sean Wieland Piper Jaffray Buy   Aug 25, '17     211.00  Aug 25, '18  N/A 
< previous1234567